Vanholder R - Search Results

1

Progression of renal failure in patients with compromised renal function is not always present: evaluation of underlying disease.

Rottey S, Vanholder R, De Schoenmakere G, Lameire N. Rottey S, et al. Among authors: vanholder r. Clin Nephrol. 2000 Jul;54(1):1-10. Clin Nephrol. 2000. PMID: 10939750

2

Acute renal failure in the elderly.

Lameire N, Nelde A, Hoeben H, Vanholder R. Lameire N, et al. Among authors: vanholder r. Geriatr Nephrol Urol. 1999;9(3):153-65. doi: 10.1023/a:1008322515136. Geriatr Nephrol Urol. 1999. PMID: 10701138 Review. No abstract available.

3

Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients.

De Schoenmakere G, Vanholder R, Rottey S, Duym P, Lameire N. De Schoenmakere G, et al. Among authors: vanholder r. Nephrol Dial Transplant. 2001 Sep;16(9):1850-5. doi: 10.1093/ndt/16.9.1850. Nephrol Dial Transplant. 2001. PMID: 11522869

4

Dyspepsia and gastric emptying in chronic renal failure patients.

Van Vlem B, Schoonjans R, Vanholder R, Vandamme W, De Vos M, Lameire N. Van Vlem B, et al. Among authors: vanholder r. Clin Nephrol. 2001 Oct;56(4):302-7. Clin Nephrol. 2001. PMID: 11680660

5

The epidemic of cardio-vascular disease in renal failure: where does it come from, where do we go?

Vanholder R, Van Biesen W, Verbeke F, Lameire N. Vanholder R, et al. Acta Clin Belg. 2006 Sep-Oct;61(5):205-11. doi: 10.1179/acb.2006.035. Acta Clin Belg. 2006. PMID: 17240733 Review.

6

Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin.

Veys N, Vanholder R, Lameire N. Veys N, et al. Among authors: vanholder r. Am J Nephrol. 1992;12(1-2):68-72. doi: 10.1159/000168420. Am J Nephrol. 1992. PMID: 1415368 Clinical Trial.

7

Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.

Van Loo A, Vanholder R, Madsen K, Praet M, Kint J, De Paepe A, Messiaen L, Lameire N, Hasholt L, Sørensen SA, Ringoir S. Van Loo A, et al. Among authors: vanholder r. Am J Nephrol. 1996;16(4):352-7. doi: 10.1159/000169023. Am J Nephrol. 1996. PMID: 8739292

8

Recombinant human erythropoietin corrects anaemia during the first weeks after renal transplantation: a randomized prospective study.

Van Loo A, Vanholder R, Bernaert P, De Roose J, Lameire N. Van Loo A, et al. Among authors: vanholder r. Nephrol Dial Transplant. 1996 Sep;11(9):1815-21. doi: 10.1093/oxfordjournals.ndt.a027674. Nephrol Dial Transplant. 1996. PMID: 8918628 Clinical Trial.

9

The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).

De Schoenmakere G, Lameire N, Dhondt A, Van Loo A, Van der Goten J, Duym P, Vanholder R. De Schoenmakere G, et al. Among authors: vanholder r. Nephrol Dial Transplant. 1998 Jul;13(7):1770-5. doi: 10.1093/ndt/13.7.1770. Nephrol Dial Transplant. 1998. PMID: 9681726 Clinical Trial.

10

Chronic kidney disease as cause of cardiovascular morbidity and mortality.

Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N; European Uremic Toxin Work Group. Vanholder R, et al. Nephrol Dial Transplant. 2005 Jun;20(6):1048-56. doi: 10.1093/ndt/gfh813. Epub 2005 Apr 6. Nephrol Dial Transplant. 2005. PMID: 15814534 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

879 results

Search Page

Filters